Filing Details
- Accession Number:
- 0001968202-24-000048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-05 16:05:50
- Reporting Period:
- 2024-02-01
- Accepted Time:
- 2024-02-05 16:05:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187443 | F Arthur Ryan | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-02-01 | 1 | $939.53 | 18,481 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 6 | $941.91 | 18,475 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 5 | $942.50 | 18,470 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 3 | $943.54 | 18,467 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 1 | $944.66 | 18,466 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 3 | $947.37 | 18,463 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 1 | $948.77 | 18,462 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 10 | $949.48 | 18,452 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 2 | $950.01 | 18,450 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 3 | $951.40 | 18,447 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 3 | $953.18 | 18,444 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 5 | $954.52 | 18,439 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 10 | $955.35 | 18,429 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 7 | $956.21 | 18,422 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 3 | $957.75 | 18,419 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 5 | $958.65 | 18,414 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 8 | $959.68 | 18,406 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 10 | $960.52 | 18,396 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 4 | $961.37 | 18,392 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 6 | $962.49 | 18,386 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-01 | 4 | $963.73 | 18,382 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.
- Represents volume-weighted average price of sales of 6 shares of Company stock on February 1, 2024 at prices ranging from $941.83 to $941.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2024 at prices ranging from $942.03 to $942.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $943.49 to $943.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $947.16 to $947.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 10 shares of Company stock on February 1, 2024 at prices ranging from $949.13 to $949.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2024 at prices ranging from $950.00 to $950.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $951.10 to $951.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $953.12 to $953.26. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2024 at prices ranging from $954.15 to $954.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 10 shares of Company stock on February 1, 2024 at prices ranging from $955.11 to $955.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2024 at prices ranging from $956.00 to $956.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2024 at prices ranging from $957.32 to $957.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2024 at prices ranging from $958.48 to $958.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 8 shares of Company stock on February 1, 2024 at prices ranging from $959.14 to $959.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 10 shares of Company stock on February 1, 2024 at prices ranging from $960.18 to $960.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2024 at prices ranging from $961.00 to $961.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 6 shares of Company stock on February 1, 2024 at prices ranging from $962.20 to $962.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.
- Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2024 at prices ranging from $963.54 to $963.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2024 at each separate price.